Milestone Scientific Q1 2024 GAAP EPS $(0.02), Inline, Sales $2.249M Miss $2.416M Estimate
Portfolio Pulse from Benzinga Newsdesk
Milestone Scientific (AMEX:MLSS) reported Q1 2024 GAAP EPS of $(0.02), meeting analyst expectations, but missed sales estimates with $2.249M, a 13.43% decrease from the same period last year.
May 16, 2024 | 11:19 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Milestone Scientific reported Q1 2024 GAAP EPS of $(0.02), meeting analyst expectations, but missed sales estimates with $2.249M, a 13.43% decrease from the same period last year.
While the EPS met expectations, the significant miss on sales and the year-over-year decline in revenue are likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100